Synergistic Impact of d-δ-Tocotrienol and Geranylgeraniol on the Growth and HMG CoA Reductase of Human DU145 Prostate Carcinoma Cells

References

• Goldstein JL, Brown MS: Regulation of the mevalonate pathway. Nature 343, 425–430, 1990.
   PubMed Web of Science ®Google Scholar
• McAnally JA, Jung M, Mo H: Farnesyl-O-acetylhydroquinone and geranyl-O-acetylhydroquinone suppress the proliferation of murine B16 melanoma cells, human prostate and colon adenocarcinoma cells, human lung carcinoma cells, and human leukemia cells. Cancer Lett 202, 181–192, 2003.
   PubMed Web of Science ®Google Scholar
• Mo H, Elfakhani M, Shah A, Yeganehjoo H: Mevalonate-suppressive tocotrienols for cancer chemoprevention and adjuvant therapy. In: Tocotrienols: vitamin E beyond tocopherols (2 ed.) pp. 135–149. CRC Press: Boca Raton, 2013.
   Google Scholar
• Mo H, Elson CE: Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med (Maywood) 229, 567–585, 2004.
   PubMed Web of Science ®Google Scholar
• Song BL: DeBose-Boyd RA: Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme a reductase stimulated by δ- and γ-tocotrienols. J Biol Chem 281, 25054–25061, 2006.
   PubMed Web of Science ®Google Scholar
• Sever N, Song BL, Yabe D, Goldstein JL, Brown MS, et al.: Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol. J Biol Chem 278, 52479–52490, 2003.
   PubMed Web of Science ®Google Scholar
• Constantinou C, Neophytou CM, Vraka P, Hyatt JA, Papas KA, et al.: Induction of DNA damage and caspase-independent programmed cell death by vitamin E. Nutr Cancer 64, 136–152, 2012.
   PubMed Web of Science ®Google Scholar
• McAnally JA, Gupta J, Sodhani S, Bravo L, Mo H: Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo. Exp Biol Med (Maywood) 232, 523–531, 2007.
   PubMed Web of Science ®Google Scholar
• Fernandes NV, Yeganehjoo H, Katuru R, DeBose-Boyd R, Morris LL, et al.: Geranylgeraniol suppresses the viability of human DU145 prostate carcinoma cells and the level of HMG CoA reductase. Exp Biol Med (Maywood) 238, 1265–1274, 2013.
   PubMed Web of Science ®Google Scholar
• Krycer JR, Phan L, Brown AJ: A key regulator of cholesterol homeostasis, SREBP-2, can be targeted in prostate cancer cells with natural products. Biochemical J 446, 191–201, 2012.
   PubMed Web of Science ®Google Scholar
• Sever N, Yang T, Brown MS, Goldstein JL: DeBose-Boyd RA: Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. Mol Cell 11, 25–33, 2003.
   PubMed Web of Science ®Google Scholar
• DeBose-Boyd RA: Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res 18, 609–621, 2008.
   PubMed Web of Science ®Google Scholar
• Conte C, Floridi A, Aisa C, Piroddi M, Galli F: γ-Tocotrienol metabolism and antiproliferative effect in prostate cancer cells. Ann N Y Acad Sci 1031, 391–394, 2004.
   PubMed Web of Science ®Google Scholar
• Luk SU, Yap WN, Chiu YT, Lee DT, Ma S, et al.: Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population. Intl J Cancer 128, 2182–2191, 2011.
   PubMed Web of Science ®Google Scholar
• Odysseos AD, Vraka P, Bouralexis S, Frindlay DM, Papas A, et al.: γ-Tocotrienol triggers caspase-mediated induction of apoptosis in androgen-responsive, but not androgen unresponsive prostate cancer cells in vitro. Free Radical Res 36, 116–117, 2002.
   Web of Science ®Google Scholar
• Srivastava JK, Gupta S: Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells. Biochem Biophys Res Commun 346, 447–453, 2006.
   PubMed Web of Science ®Google Scholar
• Katuru R, Fernandes NV, Elfakhani M, Dutta D, Mills N, et al.: Mevalonate depletion mediates the suppressive impact of geranylgeraniol on murine B16 melanoma cells. Exp Biol Med (Maywood) 236, 604–613, 2011.
   PubMed Web of Science ®Google Scholar
• Masuda Y, Nakaya M, Nakajo S, Nakaya K: Geranylgeraniol potently induces caspase-3-like activity during apoptosis in human leukemia U937 cells. Biochem Biophys Res Commun 234, 641–645, 1997.
   PubMed Web of Science ®Google Scholar
• Ohizumi H, Masuda Y, Nakajo S, Sakai I, Ohsawa S, et al.: Geranylgeraniol is a potent inducer of apoptosis in tumor cells. J Biochem 117, 11–13, 1995.
   PubMed Web of Science ®Google Scholar
• Ohizumi H, Masuda Y, Yoda M, Hashimoto S, Aiuchi T, et al.: Induction of apoptosis in various tumor cell lines by geranylgeraniol. Anticancer Res 17, 1051–1057, 1997.
   PubMed Web of Science ®Google Scholar
• Shibayama-Imazu T, Sakairi S, Watanabe A, Aiuchi T, Nakajo S, et al.: Vitamin K(2) selectively induced apoptosis in ovarian TYK-nu and pancreatic MIA PaCa-2 cells out of eight solid tumor cell lines through a mechanism different from geranylgeraniol. J Cancer Res Clin Oncol 129, 1–11, 2003.
   PubMed Web of Science ®Google Scholar
• Joo JH, Liao G, Collins JB, Grissom SF, Jetten AM: Farnesol-induced apoptosis in human lung carcinoma cells is coupled to the endoplasmic reticulum stress response. Cancer Res 67, 7929–7936, 2007.
   PubMed Web of Science ®Google Scholar
• Miquel K, Pradines A, Favre G: Farnesol and geranylgeraniol induce actin cytoskeleton disorganization and apoptosis in A549 lung adenocarcinoma cells. Biochem Biophys Res Commun 225, 869–876, 1996.
   PubMed Web of Science ®Google Scholar
• Miquel K, Pradines A, Terce F, Selmi S, Favre G: Competitive inhibition of choline phosphotransferase by geranylgeraniol and farnesol inhibits phosphatidylcholine synthesis and induces apoptosis in human lung adenocarcinoma A549 cells. J Biol Chem 273, 26179–26186, 1998.
   PubMed Web of Science ®Google Scholar
• Takeda Y, Nakao K, Nakata K, Kawakami A, Ida H, et al.: Geranylgeraniol, an intermediate product in mevalonate pathway, induces apoptotic cell death in human hepatoma cells: death receptor-independent activation of caspase-8 with down-regulation of Bcl-xL expression. Jpn J Cancer Res 92, 918–925, 2001.
   PubMedGoogle Scholar
• Shibayama-Imazu T, Sonoda I, Sakairi S, Aiuchi T, Ann WW, et al.: Production of superoxide and dissipation of mitochondrial transmembrane potential by vitamin K2 trigger apoptosis in human ovarian cancer TYK-nu cells. Apoptosis 11, 1535–1543, 2006.
   PubMed Web of Science ®Google Scholar
• Burke YD, Stark MJ, Roach SL, Sen SE, Crowell PL: Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol. Lipids 32, 151–156, 1997.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Rao X, Kim CY, Freiser H, Zhang Q, et al.: Gamma-tocotrienol induces apoptosis and autophagy in prostate cancer cells by increasing intracellular dihydrosphingosine and dihydroceramide. Inter J Cancer 130, 685–693, 2012.
   PubMed Web of Science ®Google Scholar
• Barve A, Khor TO, Reuhl K, Reddy B, Newmark H, et al.: Mixed tocotrienols inhibit prostate carcinogenesis in TRAMP mice. Nutr Cancer 62, 789–794, 2010.
   PubMed Web of Science ®Google Scholar
• Qureshi AA, Pearce BC, Nor RM, Gapor A, Peterson DM, et al.: Dietary α-tocopherol attenuates the impact of γ-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens. J Nutr 126, 389–394, 1996.
   PubMed Web of Science ®Google Scholar
• Shibata A, Nakagawa K, Tsuduki T, Miyazawa T: alpha-Tocopherol suppresses antiangiogenic effect of delta-tocotrienol in human umbilical vein endothelial cells. J Nutr Biochem 26, 345–350, 2015.
   PubMed Web of Science ®Google Scholar
• de Moura Espindola R, Mazzantini RP, Ong TP, de Conti A, Heidor R, et al.: Geranylgeraniol and β-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-κB activation. Carcinogenesis 26, 1091–1099, 2005.
   PubMed Web of Science ®Google Scholar
• Giriwono PE, Shirakawa H, Ohsaki Y, Hata S, Kuriyama H, et al.: Dietary supplementation with geranylgeraniol suppresses lipopolysaccharide-induced inflammation via inhibition of nuclear factor-kappaB activation in rats. Eur J Nutr 52, 1191–1199, 2013.
   PubMed Web of Science ®Google Scholar
• Vitols S, Norgren S, Juliusson G, Tatidis L, Luthman H: Multilevel regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in normal and leukemic cells. Blood 84, 2689–2698, 1994.
   PubMed Web of Science ®Google Scholar
• Yachnin S, Mannickarottu V: Increased 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol biosynthesis in freshly isolated hairy cell leukemia cells. Blood 63, 690–693, 1984.
   PubMed Web of Science ®Google Scholar
• Bennis F, Favre G, Le Gaillard F, Soula G: Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549. Int J Cancer 55, 640–645, 1993.
   PubMed Web of Science ®Google Scholar
• Hentosh P, Yuh SH, Elson CE, Peffley DM: Sterol-independent regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in tumor cells. Mol Carcinog 32, 154–166, 2001.
   PubMed Web of Science ®Google Scholar
• Parker RA, Pearce BC, Clark RW, Gordon DA, Wright JJ: Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem 268, 11230–11238, 1993.
   PubMed Web of Science ®Google Scholar
• Pearce BC, Parker RA, Deason ME, Qureshi AA, Wright JJ: Hypocholesterolemic activity of synthetic and natural tocotrienols. J Med Chem 35, 3595–3606, 1992.
   PubMed Web of Science ®Google Scholar
• Qureshi AA, Burger WC, Peterson DM, Elson CE: The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J Biol Chem 261, 10544–10550, 1986.
   PubMed Web of Science ®Google Scholar
• Ownby SE, Hohl RJ: Farnesol and geranylgeraniol: prevention and reversion of lovastatin-induced effects in NIH3T3 cells. Lipids 37, 185–192, 2002.
   PubMed Web of Science ®Google Scholar
• Houten SM, Schneiders MS, Wanders RJ, Waterham HR: Regulation of isoprenoid/cholesterol biosynthesis in cells from mevalonate kinase-deficient patients. J Biol Chem 278, 5736–5743, 2003.
   PubMed Web of Science ®Google Scholar
• Patacsil D, Tran AT, Cho YS, Suy S, Saenz F, et al.: Gamma-tocotrienol induced apoptosis is associated with unfolded protein response in human breast cancer cells. J Nutr Biochem 23, 93–100, 2012.
   PubMed Web of Science ®Google Scholar
• Yap WN, Zaiden N, Tan YL, Ngoh CP, Zhang XW, et al.: Id1, inhibitor of differentiation, is a key protein mediating anti-tumor responses of gamma-tocotrienol in breast cancer cells. Cancer Lett 291, 187–199, 2010.
   PubMed Web of Science ®Google Scholar
• Husain K, Francois RA, Yamauchi T, Perez M, Sebti SM, et al.: Vitamin E δ-tocotrienol augments the anti-tumor activity of gemcitabine and suppresses constitutive NFκB activation in pancreatic cancer. Mol Cancer Ther 10, 2363–2372, 2011.
   PubMed Web of Science ®Google Scholar
• Shin-Kang S, Ramsauer VP, Lightner J, Chakraborty K, Stone W, et al.: Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway. Free Radic Biol Med 51, 1164–1174, 2011.
   PubMed Web of Science ®Google Scholar
• Yap WN, Chang PN, Han HY, Lee DTW, Ling MT, et al.: γ-Tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways. Br J Cancer 99, 1832–1841, 2008.
   PubMed Web of Science ®Google Scholar
• Fernandes NV, Guntipalli PK, Mo H: d-δ-Tocotrienol-mediated cell cycle arrest and apoptosis in human melanoma cells. Anticancer Res 30, 4937–4944, 2010.
   PubMed Web of Science ®Google Scholar
• Oades GM, Senaratne SG, Clarke IA, Kirby RS, Colston KW: Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells. J Urol 170, 246–252, 2003.
   PubMed Web of Science ®Google Scholar
• Pergolizzi RG, Kreis W, Rottach C, Susin M, Broome JD: Mutational status of codons 12 and 13 of the N- and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas. Cancer Invest 11, 25–32, 1993.
   PubMed Web of Science ®Google Scholar
• Omerovic J, Hammond DE, Clague MJ, Prior IA: Ras isoform abundance and signalling in human cancer cell lines. Oncogene 27, 2754–2762, 2008.
   PubMed Web of Science ®Google Scholar
• Constantinou C, Hyatt JA, Vraka PS, Papas A, Papas KA, et al.: Induction of caspase-independent programmed cell death by vitamin E natural homologs and synthetic derivatives. Nutr Cancer 61, 864–874, 2009.
   PubMed Web of Science ®Google Scholar
• Jones S, Fernandes NV, Yeganehjoo H, Katuru R, Qu H, et al.: β-Ionone induces cell cycle arrest and apoptosis in human prostate tumor cells. Nutr Cancer 65, 600–610, 2013.
   PubMed Web of Science ®Google Scholar
• He L, Mo H, Hadisusilo S, Qureshi AA, Elson CE: Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J Nutr 127, 668–674, 1997.
   PubMed Web of Science ®Google Scholar
• Mo H, Elson CE: Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids. J Nutr 129, 804–813, 1999.
   PubMed Web of Science ®Google Scholar
• Tatman D, Mo H: Volatile isoprenoid constituents of fruits, vegetables and herbs cumulatively suppress the proliferation of murine B16 melanoma and human HL-60 leukemia cells. Cancer Lett 175, 129–139, 2002.
   PubMed Web of Science ®Google Scholar
• Hussein D, Mo H: d-δ-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa2 and BxPC-3 pancreatic carcinoma cells. Pancreas 38, e124–136, 2009.
   PubMed Web of Science ®Google Scholar
• Qureshi AA, Khan DA, Saleem S, Silswal N, Trias AM, et al.: Pharmacokinetics and bioavailability of Annatto δ-tocotrienol in healthy fed subjects. J Clin Exp Cardiol 6, 411, 2015.
   Google Scholar
• Muraguchi T, Okamoto K, Mitake M, Ogawa H, Shidoji Y: Polished rice as natural sources of cancer-preventing geranylgeranoic acid. J Clin Biochem Nutr 49, 8–15, 2011.
   PubMed Web of Science ®Google Scholar
• Pan MH, Lai CS, Dushenkov S, Ho CT: Modulation of inflammatory genes by natural dietary bioactive compounds. J Agric Food Chem 57, 4467–4477, 2009.
   PubMed Web of Science ®Google Scholar